Rekord LOINC: 21948-5
Tylko wersja angielska ACTIVE
Szczegóły rekordu LOINC
Informacje podstawowe
| Kod LOINC: |
21948-5
FHIR
|
| Long Common Name: | Biological response modifier treatment Cancer |
| Short Name: | Biological response modifier Rx Cancer |
| Status: | ACTIVE |
| Class Type: | 2 |
Fully Specified Name (FSN)
Klasyfikacja
| Class: |
ENTUMRRGT
|
| Consumer Name: | - |
| Order/Observation: | - |
| Panel Type: | - |
Informacje dodatkowe
| Units Required: | - |
| Example Units: | - |
| UCUM Units: | - |
| Version Last Changed: | 2.29 |
Definicja i opis
Records whether immunotherapeutic (biologic response modifiers) agents were administered as first-course treatment at this facility or the reason they were not given. Immunotherapy consists of biological or chemical agents that alter the immune system or change the host's response to tumor cells. Systemic therapy may involve the administration of one or a combination of agents. This data item allows for the evaluation of the administration of immunotherapeutic agents as part of the first course of therapy.. NAACCR Data Standards and Data Dictionary Version 11
Powiązane nazwy
BRM; CA; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; To be specified in another part of the message; Treatment; TUMOR REGISTRY(NAACCR); Typ; Unspecified